MORE gradual approaches to quitting will become possible for smoker patients struggling to quit, as a result of the PBS listing relaxation for Champix (varenicline) from Authority Required to the Streamlined authority status, Pfizer Australia has announced.
Effective 01 May, the 'gradual approach to quitting' enables patients taking Champix to reduce smoking consumption by 50% within the first 4 weeks, a further 50% in the next 4 weeks and then continue reducing with the goal of reaching complete abstinence by 12 weeks.
Patients then continue taking Champix for an additional consolidating 12 weeks for a total of 24 weeks of treatment.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Apr 17
